May Lee Tjoa, PhD

Janssen Global Services, LLC

Poster(s):

• (48) Effectiveness and safety of antenatal treatments for fetal and neonatal alloimmune thrombocytopenia (FNAIT)
  Thursday, September 26, 2024

  12:15 - 13:30 CET

• (168) Clinical characteristics and pregnancy outcomes in pregnancies at-risk of HDFN in Sweden, Finland, and Denmark
  Thursday, September 26, 2024

  17:15 - 18:30 CET

• (169) Retrospective analysis of neonatal outcomes in pregnancies at-risk of HDFN in Sweden, Finland, and Denmark
  Thursday, September 26, 2024

  17:15 - 18:30 CET